MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSTION SUMMARY
As Senior Manager, SEC Financial Reporting and Technical Accounting, you will be an integral part of the preparation of financial statements in compliance with US GAAP and SEC guidelines, serve as a technical accounting expert and assist in managing the SOX program for the organization. This individual interacts with various levels of management within the accounting/finance organization and third parties across financial and operational projects and initiatives. The ideal candidate is a licensed CPA with extensive biotechnology and/or pharmaceutical experience. This position reports directly to the Executive Director, SEC Reporting & Technical Accounting.
JOB FUNCTIONS/RESPONSIBILITIES
- Assist in the preparation of the quarterly and annual SEC filing on Forms 10-K and 10Q.
- Compile financial statements and footnote disclosures, as well as assist in analysis for management disclosures and other SEC disclosures.
- Ensure financial statements are prepared in accordance with US GAAP and SEC regulations, including newly issued accounting pronouncements.
- Perform technical accounting research as needed on significant or unusual transactions.
- Assist with ASC 606 revenue recognition matters for the company.
- Recommend, implement, maintain and communicate accounting policies and procedures to ensure integrity and consistency of application throughout the organization.
- Responsible for stock-based compensation accounting.
- Assist with the Company’s 404 SOX compliance program including evaluating the adequacy of controls at existing and proposed new service organizations based on reporting provided by the service organizations.
- Work with Company’s external SOX partners to ensure timely completion of management testing of controls.
- Assist with preparation of the annual proxy statement and other ad hoc filings.
- Prepare supporting schedules for audit committee presentations.
- Other ad hoc projects as needed.
QUALIFICATIONS
Education/Experience:
- Strong US GAAP and compliance experience .
- Minimum 5 years of progressive accounting experience including 2-3 years in a public company, at a minimum.
- CPA and Big Four experience auditing biotech companies is strongly preferred.
- Workiva experience preferred
- SEC reporting, technical accounting experience, plus operations in a SOX 404(b) environment preferred.
- Candidate performs with strong sense of urgency and works effectively under deadlines.
- Attention to detail and ability to multi-task.
- Strong written and verbal communication skills.
Education:
- Bachelor or master’s degree in accounting
- CPA required
Knowledge, Skills and Abilities:
- Strong work ethic.
- Strong analytical skill.
- Excellent written and verbal communication skills.
- Self-starter with ability to prioritize workload.
- Candidate performs with strong sense of urgency and works effectively under deadlines.
- Attention to detail and ability to multi-task.
The salary range for this position is $170,000 to $190,000 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.
#LI-HYBRID
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Top Skills
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older.
Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome.
Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome.
Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
